ERS Genomics and KU Leuven sign a CRISPR/Cas9 License Agreement to expand the services of research enabled by CRISPT

Summary

The agreement gives KU Leuven's Leuven Viral Vector Core access to the fundamental CRISPR/Cas9 intellectual property, supporting genome editing services for academic and industry researchers worldwide DUBLIN, and LEUVEN, Bel...